Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 764
Last updated 2013-01-15
Summary
In vitro identification of S. aureus,methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA)from positive blood culture using MicroPhage's bacteriophage-based diagnostic platform.
Conditions
- Bacteremia
Sponsors & Collaborators
-
MicroPhage, Inc.
lead INDUSTRY
Principal Investigators
-
Dipankar Manna, Ph.D. · MicroPhage, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
NCT01898208 ·Status: COMPLETED ·Phase: NA
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
NCT03693495 ·Status: WITHDRAWN ·Phase: NA
-
Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections
NCT01198262 ·Status: COMPLETED
-
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
NCT03361163 ·Status: COMPLETED ·Phase: PHASE1
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)
NCT02684422 ·Status: COMPLETED
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma
NCT02842710 ·Status: WITHDRAWN ·Phase: NA
-
Chart Review of Outcome of Treatment for S. Aureus Bacteremia
NCT00304902 ·Status: COMPLETED
-
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
NCT02862262 ·Status: COMPLETED ·Phase: NA
-
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
NCT06174649 ·Status: COMPLETED ·Phase: NA
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Preview Rapid Strep A Test Method Comparison Study
NCT03907449 ·Status: SUSPENDED
-
Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
NCT00711854 ·Status: COMPLETED ·Phase: PHASE4
-
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pathogenic Bordetella Rapid Detection
NCT04535505 ·Status: WITHDRAWN
-
Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00846105 ·Status: COMPLETED ·Phase: NA
-
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332 ·Status: RECRUITING ·Phase: PHASE4
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
MSSA and MRSA Screening in Patients Undergoing Elective TJA: the Benefits of Next-generation Sequencing
NCT04574752 ·Status: UNKNOWN
-
Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers
NCT02178488 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)
NCT00770341 ·Status: COMPLETED ·Phase: PHASE3
-
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00087490 ·Status: COMPLETED ·Phase: PHASE4
-
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
NCT06456424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2